Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Fake clopidogrel found

  • Comment
A class one drug recall has issued after the discovery of counterfeit versions of the anti-platelet clopidogrel (Plavix).

A class one drug recall has issued after the discovery of counterfeit versions of the anti-platelet clopidogrel (Plavix).

The Medicines and Healthcare products Regulatory Agency is recalling any parallel distributed stock of Lots 3098 and 6Y098 (and lot variants) of clopidogrel tablets 75 mg branded as Plavix.

The agency said: 'Initial tests show that samples only contain about 70-80% of the labelled active ingredient. In addition, a counterfeit is likely to show a different bioavailability profile and may contain harmful degradants.'

It said the counterfeits were supplied in French livery via parallel distributors into the UK supply chain. Stock presenting a patient risk may be present as French livery cartons with an overlabel applied by a parallel distributor or may have been recartoned into an English carton by the parallel distribution repacking process.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.